Publications

5808 Results

Automating Data Entry from Electronic Health Record to Electronic Data Capture Using Trusted Cloud-based Application in Multi-site Cancer Clinical Trials

Authors
K Goodman;C Cook;D Weatherbee;S Yadav;D Mudaranthakam;R Sexton;N Mahaffey;L Garcia;T Ta;E Cebula;J Smart;T Goudeau;A Annis;A Gilmore;D Chugina;P Ahmadzai;A Hoering;M LeBlanc
Journal / Conference
Journal of the Society for Clinical Data Management Winter;5(1):1-16; doi: 10.47912/jscdm.371; Epub 2025 Jan 14
Year
2025
Research Committee(s)
Cancer Care Delivery and Multiple sites
PMID
PMID40510739
PMC
PMC12162058

Minimal residual disease status predicts outcomes in patients with follicular lymphoma treated with chemo-immunotherapy on SWOG S0016

Authors
A Danilov;H Li;M Shadman;L Rimsza;A Zebari;S Smith;M LeBlanc;J Friedberg;C Carlson;J Song
Journal / Conference
Haematologica. 2025 Dec 1;110(12):3145-3149. doi: 10.3324/haematol.2025.288057. Epub 2025 Jul 3.
Year
2025
Research Committee(s)
Lymphoma
PMID
PMID40605713
PMC
PMC12666269
Study Number(s)
S0016

Cancer in rural America: Improving access to clinical trials and quality of oncologic care

Authors
J Unger;B McAneny;R Osarogiagbon
Journal / Conference
CA-A CANCER JOURNAL FOR CLINICIANS 2025 Jul-Aug;75(4):341-361
Year
2025
Research Committee(s)
Cancer Care Delivery
PMID
PMID40146038
PMC
PMC12223359

Practice patterns related to ovarian function suppression in the SWOG S2010 clinical trial of young women with breast cancer

Authors
NL Henry;J Unger;A Darke;A Schott;P Kumar;M Mazo Canola;C Sathe;P Cabrera-Galeana;A Kengla;M Fisch;D Hershman
Journal / Conference
ASCO Annual Meeting (May 30-June 3, 2025, Chicago), poster, Abstract # 522 Poster Bd # 115
Year
2025
Research Committee(s)
Symptom Management and Survivorship
Study Number(s)
S2010

Depression in Patients with Advanced Prostate Cancer in SWOG Advanced Cancer Clinical Trials

Authors
R Krouse;H Xiao;C Blanke;D Hershman;J Unger
Journal / Conference
ASCO Annual Meeting (May 30 to June 3, 2025, Chicago, Il) Abstract #12090; Poster Bd #110; J Clin Oncol 43, 12090(2025); Volume 43, Number 16_suppl; DOI: 10.1200/JCO.2025.43.16_suppl.12090
Year
2025

Longitudinal changes in credit status for newly diagnosed metastatic colorectal cancer patients

Authors
N Kwendakwema;A Darke;J Unger;D Hershman;S Ramsey;V Shankaran
Journal / Conference
ASCO Annual Meeting (May 30 to June 3, 2025, Chicago, Il), poster, Abstract # 11076 Poster Bd # 415
Year
2025
Research Committee(s)
Cancer Care Delivery
Study Number(s)
S1417CD

Successful implementation of a cluster randomized controlled trial (RCT) comparing an educationally enhanced genomic tumor board (EGTB) intervention to usual practice to increase evidence-based genome-informed therapy (S2108CD, NCT# 05455606)

Authors
M Trivedi;J Rueter;J Unger;K Arnold;S Colby;K Reed;J Fischer;L Kelley;P Kumar;B Faller;K Rowland;D Nikcevich;B Symington;P Tseng;V Shankaran;S Ramsey;D Hershman
Journal / Conference
ASCO Annual Meeting (May 30 to June 3, 2025, Chicago, Il), poster, Abstract # 1544 Poster Bd # 297
Year
2025
Research Committee(s)
Cancer Care Delivery
Study Number(s)
S2108CD

Impact of the COVID-19 Pandemic Mitigation Strategies on Cancer Treatment Trials: A Meta-Analysis of Industry and National Cancer Institute Studies

Authors
J Unger;H Andrews;L Levit;B McKelvey;M Stewart;B Canin;K Flaherty;D Kimball;T Miller;A Onitilo;S Bruinooge;E Garrett-Mayer;C Schenkel
Journal / Conference
JCO Oncol Adv. 2025 Jun 13;2(1):e2500021. doi: 10.1200/OA-25-00021. eCollection 2025 Jun.
Year
2025
Research Committee(s)
Cancer Care Delivery
PMID
PMID40546794
PMC
PMC12178165

Neoadjuvant versus adjuvant pembrolizumab for resectable Stage III-IV melanoma (SWOG S1801)

Authors
S Patel;M Othus;V Prieto;M Lowe;E Buchbinder;Y Chae;P Wright;J Hyngstrom;C Lao;T-G Truong;S Chandra;K Kendra;C Devoe;A Mangla;A Ikeguchi;L Korde;J Moon;V Sondak;A Ribas
Journal / Conference
ESMO (Berlin, Germany 17-21 October 2025)
Year
2025
Research Committee(s)
Melanoma
Study Number(s)
S1801

A phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART) SWOG S1609: durable responses and delayed pseudoprogression in small cell carcinoma of the ovary, hypercalcemic type cohort

Authors
YK Chae;M Othus;S Patel;R Aljumaly;K Win;T Pejovic;S Thomas;W Robinson;H Kim;I Chung;C McLeod;H Chen;E Sharon;H Streicher;C Ryan;C Blanke;R Kurzrock
Journal / Conference
Cancer Communications Aug;45(8):976-986
Year
2025
Research Committee(s)
Early Therapeutics and Rare Cancers
PMID
PMID40402690
PMC
PMC12365539
Study Number(s)
S1609